Related Experiment Video
Updated: Aug 4, 2025

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells
Jing Zhang1, Christina Trojel-Hansen2,3, Jianghuang Wang4
1Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. jingzhang@shsmu.edu.cn.
Abstract:
Many anticancer agents induce apoptosis, mitotic catastrophe or cellular senescence. Here, we report the functional characterization of an experimental inducer of tumor necrosis factor (TNF)-independent necrosis, necrocide-1 (NC1). NC1 (but not its stereoisomer) killed a panel of human cancer cells (but not normal cells) at nanomolar concentrations and with a non-apoptotic, necrotic morphotype, both in vitro and in vivo. NC1-induced killing was not inhibited by caspase blockers, anti-apoptotic BCL2 overexpression or TNFα neutralization, suggesting that NC1 elicits a bona fide necrotic pathway. However, pharmacological or genetic inhibition of necroptosis, pyroptosis and ferroptosis failed to block NC1-mediated cell death. Instead, NC1 elicited reactive oxygen species (ROS) production by mitochondria, and elimination of mitochondrial DNA, quenching of mitochondrial ROS, as well as blockade of mitochondrial permeability transition with cyclosporine A, interfered with NC1-induced cell death. NC1 induced hallmarks of immunogenic cell death incurring calreticulin (CALR) exposure, ATP secretion and high mobility group box 1 (HMGB1) release. Taken together, these data identify a previously uncharacterized signaling cascade leading to an immunogenic variant of mitochondrion-regulated necrosis, supporting the notion that eliciting regulated necrosis may constitute a valid approach for anticancer therapy.
Insights
A novel compound, necrocide-1 (NC1), selectively kills cancer cells via a unique necrotic pathway. This tumor necrosis factor-independent mechanism involves mitochondria and triggers an immunogenic cell death response, offering a new anticancer therapy strategy.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Anticancer agents commonly induce apoptosis, mitotic catastrophe, or senescence.
- Targeting cancer cell death pathways is crucial for effective therapy.
Purpose of the Study:
- To functionally characterize necrocide-1 (NC1), an experimental inducer of tumor necrosis factor (TNF)-independent necrosis.
- To elucidate the mechanism of NC1-induced cancer cell death and its therapeutic potential.
Main Methods:
- In vitro and in vivo studies using a panel of human cancer cells and normal cells.
- Assessment of cell death morphotype, inhibition studies with caspase blockers, BCL2 overexpression, and TNFα neutralization.
- Pharmacological and genetic inhibition of necroptosis, pyroptosis, and ferroptosis.
- Mitochondrial reactive oxygen species (ROS) production and mitochondrial DNA (mtDNA) analysis.
- Cyclosporine A treatment to block mitochondrial permeability transition.
- Analysis of immunogenic cell death markers: calreticulin (CALR) exposure, ATP secretion, and high mobility group box 1 (HMGB1) release.
Main Results:
- NC1 selectively killed cancer cells (but not normal cells) at nanomolar concentrations via necrosis, independent of TNFα.
- NC1-induced cell death was not blocked by inhibiting apoptosis, necroptosis, pyroptosis, or ferroptosis.
- NC1 triggered mitochondrial ROS production and its inhibition affected cell death.
- NC1 induced hallmarks of immunogenic cell death, including CALR exposure, ATP secretion, and HMGB1 release.
Conclusions:
- NC1 elicits a novel, TNF-independent necrotic pathway regulated by mitochondria.
- This pathway is distinct from known forms of regulated cell death (necroptosis, pyroptosis, ferroptosis).
- NC1 induces immunogenic cell death, suggesting its potential as a novel anticancer therapeutic agent.
More Related Videos
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Extrinsic Apoptotic Pathway
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

